NewsOnAir
CDSCO Identifies 330 Drug Samples as Substandard in September 2026
Image unavailable
The Central Drugs Standard Control Organisation (CDSCO) reported that 330 drug samples were deemed not of standard quality in September 2026. This included 42 samples identified by Central Drugs Laboratories and 288 by State Drugs Testing Laboratories. The classification is based on the samples failing to meet specified quality parameters, but it only pertains to products tested by government laboratories. CDSCO emphasized that this ongoing effort, in collaboration with state regulators, aims to ensure that substandard and spurious medicines are identified and removed from the market.
The Radius summarizes this story. Read the original report from NewsOnAir.
Read Full